APG Asset Management’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-620,596
Closed -$24.6M 682
2024
Q1
$24.6M Buy
620,596
+360,846
+139% +$14.9M 0.04% 316
2023
Q4
$8.71M Buy
259,750
+96,287
+59% +$3.46M 0.02% 420
2023
Q3
$5.93M Buy
+163,463
New +$5.8M 0.01% 466
2023
Q2
Sell
-94,633
Closed -$3.1M 751
2023
Q1
$3.1M Sell
94,633
-39,000
-29% -$1.36M 0.01% 535
2022
Q4
$4.7M Buy
+133,633
New +$4.45M 0.01% 532

Other funds holding GSK

APG Asset Management's GSK Position: Q2 2024 in Review

APG Asset Management sold out of GSK (GSK) in Q2 2024, closing a stake of 620,596 shares — an estimated $24.6M sold.

APG Asset Management first reported a position in GSK in Q4 2022 and held it in 5 quarters. The position peaked at $24.6M in Q1 2024. 884 funds tracked by Wall St. Rank hold GSK as of Q2 2024.

  • APG Asset Management reported no remaining GSK position as of Q2 2024 after selling out during the quarter.
  • APG Asset Management sold 620,596 GSK shares in Q2 2024, an estimated $24.6M.
  • APG Asset Management first reported a position in GSK in Q4 2022 and held it in 5 quarters.
  • APG Asset Management's GSK position peaked at $24.6M in Q1 2024.
  • 884 funds tracked by Wall St. Rank held GSK as of Q2 2024.

Based on APG Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.